Patents by Inventor Luis Antonio Cano

Luis Antonio Cano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180346565
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: July 30, 2018
    Publication date: December 6, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: WILLIAM ROBERT ARATHOON, ISHAI PADAWER, LUIS ANTONIO CANO, VIKRAM NATWARSINHJI SISODIYA, KARTHIK NARAYAN MANI, DAVID LIU
  • Patent number: 10035853
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: July 31, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: William Robert Arathoon, Ishai Padawer, Luis Antonio Cano, Vikram Natwarsinhji Sisodiya, Karthik Narayan Mani, David Liu
  • Publication number: 20160175460
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: February 29, 2016
    Publication date: June 23, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: William Robert ARATHOON, Ishai PADAWER, Luis Antonio CANO, Vikram Natwarsinhji SISODIYA, Karthik Narayan MANI, David LIU
  • Publication number: 20160176964
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: February 29, 2016
    Publication date: June 23, 2016
    Inventors: William Robert Arathoon, Ishai Padawer, Luis Antonio Cano, Vikram Natwarsinhji Sisodiya, Karthik Narayan Mani, David Liu
  • Patent number: 7893222
    Abstract: The method is used for separating nucleic acids and other similar constructs. It involves selective introduction, enhancement, or stabilization of affinity handles such as single-strandedness in the undesired (or desired) nucleic acids as compared to the usual structure (e.g., double-strandedness) of the desired (or undesired) nucleic acids. The undesired (or desired) nucleic acids are separated from the desired (or undesired) nucleic acids due to capture by methods including but not limited to immobilized metal affinity chromatography, immobilized single-stranded DNA binding (SSB) protein, and immobilized oligonucleotides.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: February 22, 2011
    Assignees: University of Houston, Technology Licensing Co. LLC
    Inventors: Richard Coale Willson, III, Luis Antonio Cano